227 related articles for article (PubMed ID: 19138979)
1. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.
New ML; White CM; McGonigle P; McArthur DG; Dwyer-Nield LD; Merrick DT; Keith RL; Tennis MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):643-654. PubMed ID: 30045935
[TBL] [Abstract][Full Text] [Related]
3. TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.
Geraci MW
Trans Am Clin Climatol Assoc; 2018; 129():48-55. PubMed ID: 30166698
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
Falcetti E; Hall SM; Phillips PG; Patel J; Morrell NW; Haworth SG; Clapp LH
Am J Respir Crit Care Med; 2010 Nov; 182(9):1161-70. PubMed ID: 20622039
[TBL] [Abstract][Full Text] [Related]
5. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.
Dwyer-Nield L; Hickey GA; Friedman M; Choo K; McArthur DG; Tennis MA; New ML; Geraci M; Keith RL
Cancer Prev Res (Phila); 2017 Nov; 10(11):671-679. PubMed ID: 28851689
[TBL] [Abstract][Full Text] [Related]
6. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn JH; Lee KT; Choi YS; Choi JH
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
[TBL] [Abstract][Full Text] [Related]
7. Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.
Battersby S; Critchley HO; de Brum-Fernandes AJ; Jabbour HN
Reproduction; 2004 Jan; 127(1):79-86. PubMed ID: 15056772
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW
Cancer Res; 2004 Aug; 64(16):5897-904. PubMed ID: 15313935
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.
Keith RL; Karoor V; Mozer AB; Hudish TM; Le M; Miller YE
Lung Cancer; 2010 Oct; 70(1):37-42. PubMed ID: 20116128
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
Tennis MA; Van Scoyk M; Heasley LE; Vandervest K; Weiser-Evans M; Freeman S; Keith RL; Simpson P; Nemenoff RA; Winn RA
Neoplasia; 2010 Mar; 12(3):244-53. PubMed ID: 20234818
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
[TBL] [Abstract][Full Text] [Related]
12. IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
Falcetti E; Flavell DM; Staels B; Tinker A; Haworth SG; Clapp LH
Biochem Biophys Res Commun; 2007 Sep; 360(4):821-7. PubMed ID: 17624303
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
Wilson SM; Sheddan NA; Newton R; Giembycz MA
Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
[TBL] [Abstract][Full Text] [Related]
14. miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.
Smith AJ; Do P; Sompel K; Elango A; Tennis MA
Sci Rep; 2022 Feb; 12(1):2388. PubMed ID: 35149732
[TBL] [Abstract][Full Text] [Related]
15. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
Ali FY; Egan K; FitzGerald GA; Desvergne B; Wahli W; Bishop-Bailey D; Warner TD; Mitchell JA
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):242-6. PubMed ID: 16239641
[TBL] [Abstract][Full Text] [Related]
16. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin receptor signaling and early embryo development in the mouse.
Huang JC; Wun WS; Goldsby JS; Egan K; FitzGerald GA; Wu KK
Hum Reprod; 2007 Nov; 22(11):2851-6. PubMed ID: 17905746
[TBL] [Abstract][Full Text] [Related]
18. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle.
Arbab F; Goldsby J; Matijevic-Aleksic N; Huang G; Ruan KH; Huang JC
Hum Reprod; 2002 Dec; 17(12):3053-9. PubMed ID: 12456602
[TBL] [Abstract][Full Text] [Related]
20. BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13.
Molloy ES; Morgan MP; McDonnell B; O'Byrne J; McCarthy GM
Osteoarthritis Cartilage; 2007 Apr; 15(4):414-20. PubMed ID: 17123841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
